Bessemer Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-78
Closed -$3K 1913
2022
Q1
$3K Hold
78
﹤0.01% 1673
2021
Q4
$5K Hold
78
﹤0.01% 1569
2021
Q3
$5K Hold
78
﹤0.01% 1507
2021
Q2
$7K Hold
78
﹤0.01% 1386
2021
Q1
$6K Buy
+78
New +$6K ﹤0.01% 1370